Histogenics Corp (NASDAQ:HSGX)’s share price fell 2.4% during trading on Monday . The company traded as low as $0.22 and last traded at $0.23, 8,553,880 shares were traded during mid-day trading. A decline of 20% from the average session volume of 10,708,279 shares. The stock had previously closed at $0.24.

The firm has a market capitalization of $21.71 million, a P/E ratio of -0.29 and a beta of 3.10. The business has a 50-day moving average of $0.32 and a 200 day moving average of $0.41.

Histogenics Company Profile (NASDAQ:HSGX)

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

Read More: What is a CD ladder?

Receive News & Ratings for Histogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogenics and related companies with MarketBeat.com's FREE daily email newsletter.